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Relevance of deletion bReakpoint specification in 22q11.2 deletion syndRome: 
clinical management of thRee illustRative patients 
Willem m.a. verhoeven, Jos i.m. egger, and nicole de leeuw
abstract 
Objective: one of the most prevalent deletion syndromes is the common 22q11.2 deletion syndrome (22q11.2ds) 
that has a highly variable somatic and behavioural phenotype with different levels of intellectual disability and a variety 
of congenital abnormalities. nowadays, in addition to the common deletion, three subtypes are distinguished based on 
the breakpoints of the deleted 22q11.2 region, the proximal and central deletion within the common deletion, and an 
additional distal deletion in 22q11.2. the involved region determines not only the somatic anomalies, but also seems to 
play a role in the behavioural and psychopathological presentation. 
Method: from a group of 35 patients with genetically proven 22q11.2ds and a record with extensive information 
on somatic, neuropsychiatric and neuropsychological data, for each deletion subtype, the patient with the most 
comprehensive dossier was selected. their detailed case vignettes were analyzed as to the differences in psychopathology 
and treatment. 
Results: the common 22q11.2 deletion (involving both the proximal and central part) was dominated by a great 
variety of somatic anomalies and symptoms form the psychotic and mood spectrum, whereas the distal 22q11.2 deletion 
mainly showed congenital cardiac defects and anxiety bound psychopathology. in the central 22q11.2 deletion variant, 
autistic behaviours formed the core symptoms. in the common deletion, an atypical antipsychotic in combination with 
a mood stabilizer appeared to be most effective while an antidepressant agent induced long lasting effectiveness in the 
distal variant. the central variant typically presented with symptoms from the autism spectrum that did not warrant 
psychotropic intervention. 
Conclusions: the 22q11ds deletion region is of relevance for the range of somatic investigations and the assessment 
of differentiated psychopathology and may provide guidance for the treatment regimen. 
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introduction
the 22q11.2 deletion syndrome (22q11.2ds; 
omim #188400 and #192430), also called shprintzen 
syndrome, digeorge syndrome or velo-cardio-
facial syndrome (vcfs), is a multisystem disorder 
characterized by a highly variable phenotypical 
presentation and a wide iQ-variability ranging from 
mild-moderate intellectual disability to normal 
intelligence. the deletion syndrome is mostly caused 
by a ~3 Mb deletion which is flanked by low copy 
repeats (lcRs) lcR22-a to lcR22-d, encompassing 
the HIRA, TBX1 and COMT genes which, among 
others, are considered to be crucial for the clinical 
phenotype. this so called common deletion is strongly 
associated with a diversity of congenital anomalies, 
particularly vascular and renal malformations as well 
as immunodeficiency due to thymic hypoplasia and 
dysfunctions of thyroid and parathyroid. in a small 
percentage of patients with this type of deletion early-
onset parkinson disease occurs (butcher et al. 2013). 
in addition, several types of seizures may be present 
(strehlow et al. 2016). Within the common 22q11.2ds 
a distinction can be made between (a) the less frequent 
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figure 1) were described in detail with respect to their 
differences in behavioural and psychiatric history as 
well as in psychopathology and (pharmacological) 
treatment response. 
Results
Differential psychopathology
the psychopathological phenotype associated 
with a common deletion was typified by a history of 
relapsing schizophrenia-like psychosis, partial non-
response to conventional antipsychotics as well as 
by mood instability and diminished social-emotional 
functioning. anxieties and mood instability were 
manifest as well. the patient with a distal deletion 
predominantly showed anxiety symptoms as well as a 
cognitive profile characterized by deficits in problem 
solving/planning and in abstract and social thinking. 
the behaviour of the patient with a central deletion was 
characterized by symptoms from the autism spectrum 
only. 
Case vignettes
1. Common 22q11.2 deletion (AD)
the patient is a 48-year-old female born to non-
consanguineous parents and has one healthy, younger 
brother. pregnancy and delivery were unremarkable. 
early infancy was characterized by feeding problems, 
delayed milestones, especially speech and language due 
to velopharyngeal insufficiency, and recurrent upper 
airway infections. she followed special education. 
because of mood instability and suspected epilepsy 
in the absence of eeg-abnormalities, treatment with 
carbamazepine was initiated that, however, had to 
be replaced by valproic acid because of a severe 
dermatological reaction. shortly after leaving the 
parental home at the age of 22, she developed a first 
psychotic episode that was followed by three years 
psychiatric hospitalization during which period she 
was treated with a great variety of antipsychotics 
while valproic acid was continued. at discharge to 
a sheltered home facility, a diagnosis of reactive 
psychosis was made and treatment comprised valproic 
acid and bromperidol. during subsequent years, several 
psychotic relapses occurred characterized by paranoid 
ideation, auditory hallucinations, mood instability with 
intermittent ideas of grandiosity, crying, and an increase 
of pre-existent challenging aggressive behaviours. 
since antipsychotics (bromperidol, levomepromazine, 
sulpiride, haloperidol) provided no further amelioration, 
from the age of 30 years extensive assessments were 
performed. ct-brain and echo abdomen disclosed 
no abnormalities whereas echo heart demonstrated a 
borderline enlargement of the thoracic aorta. in addition, 
hypoparathyroidism was diagnosed as well as psoriasis 
inversa/pustulosa. FISH analysis with a probe specific 
for the hiRa region disclosed a de novo deletion in 
22q11.2. treatment comprised 200 mg sulpiride, 2 mg 
haloperidol, 1000 mg valproic acid, 2 μg alfacalcidol 
and 1500 μg calcium/cholecalciferol. Two years before 
the present referral, psychological assessment was 
performed that disclosed mild intellectual disability 
with Wisc-iii total intelligence and vabs/esseon 
socio-emotional functioning corresponding with an age 
of 7;2 years and 2;6 years, respectively. 
the patient was referred because of increasing 
challenging behaviours with great impact on her care 
central variant located between lcR22-b and lcR22-d 
comprising the SERPIND1, LZRT1, and CRKL genes, 
and (b) the proximal variant (lcR22-a to lcR22-b) 
encompassing the HIRA, TBX1, and COMT genes. the 
former rather than the latter is predominantly associated 
with renal and urogenital anomalies and to a lesser 
extent with cardiac malformations (Rump et al. 2014).
in addition to the proximal and central variant, 
also, a 22q11.2ds variant is described that is caused 
by a deletion distal from the common deletion (distal 
of lcR22-d i.e., lcR22-d to lcR22-e, lcR22-f 
or lcR22-g). this distal variant may comprise the 
MAPK1, BCR, SMARCB1, and SPECC1L genes, has 
a generally mild phenotypical presentation and is 
typically associated with cardiac anomalies, including 
conotruncal defects in the absence of other relevant 
somatic dysfunctions (fagerberg et al. 2013, bengoa-
alonso et al. 2016). the different subtypes of 22q11.2ds 
with their lcRs are depicted in figure 1. given the 
multisystem condition of the 22q11.2ds, fung and 
colleagues published in 2015 practical guidelines for 
managing adults with this condition. 
not only regarding somatic anomalies but also with 
respect to psychopathology, there is some evidence 
that the above mentioned 22q11.2ds subtypes may 
also be accompanied by a differential neuropsychiatric 
profile (Burnside 2015, McDonald-McGinn et al. 
2015, Hacihamdioğlu et al. 2015). In the following, 
the putative phenotypic variability will be illustrated 
by means of concise case vignettes of three patients 
in whom, dependent on the involved lcR-region, 
a common, distal or central 22q11.2 deletion was 
demonstrated. Results will be discussed in terms 
of specific psychopathological characteristics and 
in relation to the impact of psychopharmacological 
intervention. 
method
over the past years a total of 35 genetically proven 
22q11ds patients were referred for diagnosis and 
treatment of recurrent psychiatric symptoms. in 31 
patients, a common 22q11.2 deletion (lcR22-a to 
–d) was detected (female: n=17; male: n=14; age 
range 16-70 years). in three patients, a distal deletion 
was present (lcR22-d to –e: patients de1 and de2 
in figure 1; and one lcR22-e to –f: patient ef in 
figure 1). in one patient, a central 22q11.2 deletion 
was demonstrated (lcR22-b to –d: patient bd in 
figure 1). two out of the patients with a common 
deletion (male: 45 years; female: 48 years) had an 
additional diagnosis of early parkinson disease. part of 
this group has been published before in a study on the 
psychopharmacological treatment of 22q11.2ds related 
psychoses (verhoeven and egger 2015). in all patients, 
a standard neuropsychiatric examination was performed 
using among others the elements of the comprehensive 
psychopathological Rating scale (cpRs; Åsberg et al. 
1978, goekoop et al. 1994) and following the format 
of the dc-ld (Royal college of psychiatrists 2001). 
Where possible, intelligence as well as cognitive and 
social-emotional functioning was assessed by means 
of validated instruments. in addition, relevant data 
from all available sources about treatment history and 
behavioural repertoire were collected. upon indication, 
the diagnostic procedure was extended with somatic, 
neurological or neuroradiological examination. 
from this group of patients, for each deletion 
subtype, the most complete case record was selected 
and the resulting three patients (ad, de2 and bd in 
givers and to re-evaluate psychopharmacological 
treatment. since the etiological diagnosis was 
established with FISH only, first genome wide array 
analysis was performed to further characterise the 
22q11.2 deletion. a de novo 2.88 mb interstitial 
deletion was found in 22q11.21 flanked by LCR22-A 
and lcR22-d, corresponding with a common 22q11.2 
deletion. somatic, neurological, neuropsychological 
and laboratory investigations did not show any new 
view points. after adjustment of psychotropics to 
finally 30 mg aripiprazole in combination with 1000 mg 
valproic acid and implementation of syndrome-specific 
guidance by the care givers, apart from incidental 
context driven referential thinking, behaviour and 
mood significantly stabilized. 
2. Distal 22q11.2 deletion (DE2)
the patient is a 17-year-old female, prematurely 
born after 35 weeks of gestation and is the only child 
of non-consanguineous, healthy parents. postnatally, 
major ventricular and minor atrial septal defects and 
patent ductus arteriosus were diagnosed for which 
she underwent surgical correction shortly thereafter. 
development was characterized by feeding problems and 
recurrent upper airway and urinary tract infections that 
necessitated hospitalizations. also, delayed milestones 
were noticed with clumsy motor functioning for which 
physical therapy was given. aged eight, anxieties, 
in particular when separated from the mother, and 
difficulties in falling asleep developed. Psychological 
assessment at that time showed borderline intellectual 
functioning with difficulties in planning, concentration, 
and calculation as well as impaired visuospatial 
perception. as a consequence, she followed special 
education. over subsequent years, although her peer 
interactions were relatively normal, she was frequently 
bullied and increasingly reported severe anxieties and 
panic attacks upon which she was referred. 
at examination, it became apparent that severe 
anxieties, mood instability, and irritability were 
typically related to stressful events and coincided with 
vague paranoid ideation and preoccupations with death. 
in addition, the patient complained about negative 
self esteem and lowered mood. physical examination 
revealed small stature, nasal speech and minor facial 
dysmorphisms. all laboratory tests were normal and 
mRi/mRa scanning of the brain revealed no structural 
or vascular abnormalities. detailed neuropsychiatric 
evaluation disclosed anxieties, affective instability, 
mood swings, mild perseverations, ideas of reference 
and some paranoid ideation as well as social withdrawal 
and impaired social skills. neuropsychological 
assessment showed a Wais-iii total iQ of 81 (viQ: 
76; piQ: 88), poor attention and concentration without 
memory impairments, and mild executive dysfunctions 
(switching, inhibition, and planning). as to personality, 
low self esteem, limited social autonomy, as well as 
enhanced suggestibility and sensitivity to external 
stimuli were noticed. 
based on her developmental and somatic history, 
extensive etiological investigation was performed 
that ultimately resulted in the detection of a de novo 
740 kb loss in 22q11.21q11.22 containing 14 known 
genes including MAPK1 and flanked by LCR22-D and 
lcR22-e, corresponding with a distal 22q11.2 deletion.
Given the findings on behaviour and 
psychopathology, a diagnosis of anxiety disorder, more 
specifically, panic disorder was made. The patient was 
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Legend to figure 1
overview of the 22q11.2 region with the low copy Repeats (lcR22) and selected genes shown, the different subtypes of 
deleted regions indicated by the horizontal arrows and the described patients by horizontal rectangular blocks. at the department 
of human genetics of the Radboud university medical center in a 10-year time frame (2007-2017), a recurrent copy number 
gain or loss in the 22q11.2 region was detected by genome wide array analysis in 173 index patients, involving 55 duplications 
and 118 deletions. of the deletions, 98 were common (lcR22a-d) of which eight proximal (7%; lcR22a-b). in addition, 
nine were central (8%; lcR22b-d) and 11 distal (9%; with breakpoints between lcR22d- and lcR22-h).
Position (Mb (hg 19)) 
Selected genes 
Low Copy Repeats 
(LCR22) 
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obvious that in patients with the common 22q11.2ds, 
a specific neuropsychological phenotype is present 
characterized by impaired visuoperceptual ability and 
a diminished comprehension of abstract and symbolic 
language (verhoeven et al. 2007, furniss et al. 2011, 
kates et al. 2015, maeder et al. 2016), whereas the 
distal 22q11.2ds may be associated with enhanced 
suggestibility and sensitivity to external stimuli without 
disturbances in social cognition (verhoeven et al. 
2011, fagerberg et al. 2013). apart from a behavioural 
profile characterized by autistic traits, so far, no specific 
neuropsychological phenotype is described in patients 
with a central 22q11.2ds.
it is well known that the common 22q11.2ds, 
especially the proximal subtype (lcR22-a to –b, 
comprising the COMT gene) is highly associated with 
schizophrenia-like psychoses and affective disorders 
(squarcione et al. 2013, schneider et al. 2014, tang 
et al. 2014, kates et al. 2015, van et al. 2017). case 
studies have suggested that the atypical antipsychotics 
quetiapine and clozapine, and perhaps also aripiprazole, 
often in combination with the mood stabilizing agent 
valproic acid, are most effective (verhoeven and 
egger 2015, butcher et al. 2015). for the treatment 
of anxiety disorders as observed in the patients with 
a distal 22q11.2ds, the ssRi citalopram seems to be 
the most appropriate choice (verhoeven et al. 2011). 
in this respect, the MAPK1 gene, although not known 
to be a disease gene, may still be involved in the 
vulnerability to mood and anxiety disorders (fagerberg 
et al. 2013, antypa et al. 2016). for patients with a 
central 22q11.2DS, no specific psychopharmacological 
treatment is available.
in conclusion, subtyping of 22q11.2ds according 
to the flanking LCRs may provide guidance  not only 
to determine which additional somatic, endocrine or 
neurological examinations have to be performed with 
their potential therapeutic consequences, but also to 
address the differential psychopathology in order to 
achieve a balanced choice of neuropsychological and 
psychopharmacological interventions that has the 
greatest chance for a long lasting effective treatment 
with the lowest risk for unwanted side effects.
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